GeorgesAzziMD

Oncology • Fort Lauderdale, FL

Hematologic Oncology

Hematology/Oncology/University of Miami/Jackson Memorial Hospital, Miami, FL

Join to view full profile

Dr. Azzi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Azzi's full profile

Already have an account?

Office
4725 N Federal Hwy
Fort Lauderdale, FL 33308
Phone+1 954-542-7700

Summary

Dr. Georges Azzi is an Oncologist based in Fort Lauderdale, FL, specializing in Hematologic Oncology. He completed his fellowship in Hematology and Medical Oncology at the University of Miami/Jackson Health System and his residency at Zucker School of Medicine at Hofstra/Northwell at Staten Island University Hospital. Dr. Azzi has experience in various areas, including hematologic oncology, genitourinary cancer, prostate cancer, acute myeloid leukemia, and anemia of chronic inflammation. He has also published multiple articles in highly respected journals and has been recognized for his contributions to the field, notably receiving a Travel Award from ASCO in 2015. He has been involved in clinical trials, specifically the clonoSEQ® Watch Registry.

Education & Training

University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2013 - 2016
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2010 - 2013
St Joseph's University Medical SchoolClass of 2008

Certifications & Licensure

FL State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Travel Award ASCO, 2015

Clinical Trials

The clonoSEQ® Watch Registry Start of enrollment: 2020 Oct 13
Active, not recruiting
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation Start of enrollment: 2023 Oct 25
Recruiting

Publications & Presentations

PubMed

5 citations
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
Georges Azzi, Mehrad Tavallai, Vasily N Aushev, Allyson Koyen Malashevich, Gregory P Botta
The Oncologist. 2023-03-17
5 citations
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer.
Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler
NPJ Breast Cancer. 2022-11-04
8 citations
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.
Georges Azzi, Shifra Krinshpun, Antony Tin, Minu Maninder, Allyson Koyen Malashevich
Case Reports in Oncology. 2022-05-02

Journal Articles

Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
Schutz FA, Je Y, Azzi GR, Nguyen PL, Choueiri TK, Ann Oncol, 1/29/2010

Abstracts/Posters

Rac1 inhibition as a therapeutic strategy in breast cancer.
Dana Senderoff , Georges Azzi, Erik Goka, and Marc E. Lippman, AACR International Conference on Frontiers in Basic Cancer Research, 1/1/2015
Rac1 inhibition to sensitize triple negative breast cancer to EGFR inhibition.
Georges Azzi, Erik Goka, Dana Senderoff and Marc E. Lippman, Journal of Clinical Oncology; ASCO Annual Meeting, 1/1/2015
The woman who coughed up bile: A case of bronchobiliary fistula secondary to Bevacizumab.
Georges Azzi, Kevin Alexander, ACP Annual Meeting, San Francisco, CA, 1/1/2013
Acetazolamide-induced diabetes insipidus: an idiosyncratic complication.
Chadi Saifan, Ninad Parekh, Chetana Rondla, Ali Naboush, Ahsan Khan, Georges Azzi, Yorg Azzi, Eli El-Charabaty, Suzanne El-Sayegh, American Journal Of Kidney Diseases, 1/1/2013
Effects of proton pump inhibitors and electrolytes disturbances on arrhythmias.
Elie El-Charabaty, Chadi Saifan, Mokhtar Abdallah, Ali Naboush, Daniel Glass, Georges Azzi, Yorg Azzi, Ahsan Khan, Hassan Baydoun, Chetana Rondla, Ninad Parekh, Suzann..., American Journal Of Kidney Diseases, 1/1/2013
Bevacizumab (BEV) and the risk of arterial thromboembolic events (ATE) in patients with renal cell carcinoma and other cancers: A large comprehensive meta-analysis of ...
Azzi, G. R., Schutz, F. A., Je, Y., and Choueiri, T. K., Journal of Clinical Oncology (Meeting Abstracts), 1/1/2010
Risk of congestive heart failure with VEGF-targeted therapy: A systematic review and meta-analysis of clinical trials.
Schutz, F. A., Je, Y., Azzi, G. R., and Choueiri, T. K., Journal of Clinical Oncology (Meeting Abstracts), 1/1/2010
Join now to see all

Lectures

Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
1/10/2014
Triple Negative Breast Cancer: Divide and Conquer
1/6/2014

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Reviews

Very likely to recommend September 2023

dr Azzi is a wonderful doctor, and a lovely person. He tries to answer all of my health queries in an easy to understand format. I trust Dr. Azzi with my cancer treatment regimen. He is a brilliant doctor, with a great sense of humor and a compassionate heart.